Anja Giesemann
Overview
Explore the profile of Anja Giesemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doring K, Ratuszny D, Schuppner R, Giesemann A, Bultmann E, Lanfermann H, et al.
Rofo
. 2025 Jan;
PMID: 39775573
With an incidence of 2-5 per million adults, cerebral venous and sinus thrombosis (CVST) is a rarity in the spectrum of cerebrovascular diseases. The etiology and symptomatic presentation are heterogeneous...
2.
Fenov D, Salcher R, Kludt E, Lesinski-Schiedat A, Harre J, Lenarz T, et al.
Cochlear Implants Int
. 2024 Aug;
25(3):171-181.
PMID: 39159131
Objective: The implantation of biohybrid electrodes was introduced a few years ago in our clinic. These electrodes coated with autologous mononuclear cells releasing anti-inflammatory and neuroprotective factors are thought to...
3.
Giesemann A, Schoner-Heinisch A, Gotz F, Steinemann D, Lesinski-Schiedat A, Warnecke A, et al.
Neuropediatrics
. 2024 Jul;
55(6):366-374.
PMID: 39084244
Purpose: Hamartomas of tuber cinereum present as ectopic tissue in the hypothalamic region. Clinically, the usual hypothalamic hamartomas manifest themself by gelastic seizures and pubertas praecox. We observed an increased...
4.
Doring K, Ivanyi P, Lanfermann H, Warnecke A, Giesemann A
Rofo
. 2024 Feb;
196(10):1063-1067.
PMID: 38373712
Purpose: With an incidence between 1-9/100 000 per year, Langerhans cell histiocytosis (LCH) is a rather rare disease from the hemato-oncologic disease spectrum (Hayes et al. 2009). The tumorlike disease...
5.
Stadio A, De Luca P, Koohi N, Kaski D, Ralli M, Giesemann A, et al.
Front Neurol
. 2023 Sep;
14:1204132.
PMID: 37662038
Background: Hearing can be impaired in many neurological conditions and can even represent a forme of specific disorders. Auditory function can be measured by either subjective or objective tests. Objective...
6.
Warnecke A, Staecker H, Rohde E, Gimona M, Giesemann A, Szczepek A, et al.
J Clin Med
. 2022 Dec;
11(24).
PMID: 36556073
(1) Background: Sensorineural hearing loss is a common and debilitating condition. To date, comprehensive pharmacologic interventions are not available. The complex and diverse molecular pathology that underlies hearing loss may...
7.
Grosser D, Willenborg K, Dellani P, Avallone E, Gotz F, Bothig D, et al.
Otol Neurotol
. 2021 Nov;
42(10):e1532-e1536.
PMID: 34766949
Objective: To correlate the CT imaging findings of the visibility and size of the vestibular aqueduct (VA) with the degree of the cochlear hydrops determined in MRI late imaging of...
8.
Warnecke A, Giesemann A
Laryngorhinootologie
. 2021 Aug;
100(S 01):S1-S43.
PMID: 34352899
Despite the low overall prevalence of individual rare diseases, cochlear dysfunction leading to hearing loss represents a symptom in a large proportion. The aim of this work was to provide...
9.
Salcher R, Boruchov A, Timm M, Steffens M, Giesemann A, Lenarz T, et al.
Otol Neurotol
. 2020 Oct;
42(2):242-250.
PMID: 33026778
Objective: Cochlear implants are the gold standard for patients with severe sensorineural hearing loss. A focused electrical stimulation of individual spiral ganglion neurons has not been achieved yet because the...
10.
Zelener F, Majdani O, Roemer A, Lexow G, Giesemann A, Lenarz T, et al.
Otol Neurotol
. 2019 Dec;
41(2):178-185.
PMID: 31789806
Objective: The intracochlear position of an electrode array may influence the outcome after cochlear implantation. The design of the electrode array can increase the risk of trauma causing penetration of...